Axon Enterprise, Inc. (NASDAQ:AXON) is Institute for Wealth Management LLC.’s 5th Largest Position

Institute for Wealth Management LLC. trimmed its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 0.5% during the 4th quarter, Holdings Channel reports. The fund owned 20,706 shares of the biotechnology company’s stock after selling 114 shares during the quarter. Axon Enterprise makes up about 1.5% of Institute for Wealth Management LLC.’s investment portfolio, making the stock its 5th largest position. Institute for Wealth Management LLC.’s holdings in Axon Enterprise were worth $12,306,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of AXON. Groupama Asset Managment acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA acquired a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $120,553,000. International Assets Investment Management LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at approximately $871,860,000. Westfield Capital Management Co. LP grew its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. increased its holdings in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after acquiring an additional 111,405 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird boosted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, JMP Securities boosted their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $524.85.

Axon Enterprise Price Performance

AXON stock opened at $653.43 on Friday. The business’s fifty day moving average price is $619.32 and its 200 day moving average price is $479.00. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67. The company has a market capitalization of $49.82 billion, a PE ratio of 168.85, a P/E/G ratio of 6.41 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the sale, the insider now directly owns 124,243 shares in the company, valued at approximately $77,586,026.21. This trade represents a 0.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 in the last ninety days. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.